Certain New Chemicals or Significant New Uses; Statements of Findings for December 2023

Published date20 February 2024
Record Number2024-03364
Citation89 FR 12836
CourtEnvironmental Protection Agency
SectionNotices
Federal Register, Volume 89 Issue 34 (Tuesday, February 20, 2024)
[Federal Register Volume 89, Number 34 (Tuesday, February 20, 2024)]
                [Notices]
                [Pages 12836-12837]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2024-03364]
                =======================================================================
                -----------------------------------------------------------------------
                ENVIRONMENTAL PROTECTION AGENCY
                [EPA-HQ-OPPT-2023-0098; FRL-10582-10-OCSPP]
                Certain New Chemicals or Significant New Uses; Statements of
                Findings for December 2023
                AGENCY: Environmental Protection Agency (EPA).
                ACTION: Notice.
                -----------------------------------------------------------------------
                SUMMARY: The Toxic Substances Control Act (TSCA) requires EPA to
                publish in the Federal Register a statement of its findings after its
                review of certain TSCA submissions when EPA makes a finding that a new
                chemical substance or significant new use is not likely to present an
                unreasonable risk of injury to health or the environment. Such
                statements apply to premanufacture notices (PMNs), microbial commercial
                activity notices (MCANs), and significant new use notices (SNUNs)
                submitted to EPA under TSCA. This document presents statements of
                findings made by EPA on such submissions during the period from
                December 1, 2023, to December 31, 2023.
                ADDRESSES: The docket for this action, identified by docket
                identification (ID) number EPA-HQ-OPPT-2023-0098, is available online
                at https://www.regulations.gov or in-person at the Office of Pollution
                Prevention and Toxics Docket (OPPT Docket), Environmental Protection
                Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg.,
                Rm. 3334, 1301 Constitution Ave. NW, Washington, DC. The Public Reading
                Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday,
                excluding legal holidays. The telephone number for the Public Reading
                Room is (202) 566-1744, and the telephone number for the OPPT Docket is
                (202) 566-0280. For the latest status information on EPA/DC services
                and docket access, visit https://www.epa.gov/dockets.
                FOR FURTHER INFORMATION CONTACT:
                 For technical information contact: Rebecca Edelstein, New Chemical
                Division (7405M), Office of Pollution Prevention and Toxics,
                Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
                DC 20460-0001; telephone number: (202) 564-1667 email address:
                [email protected].
                 For general information contact: The TSCA-Hotline, ABVI-Goodwill,
                422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
                554-1404; email address: [email protected].
                SUPPLEMENTARY INFORMATION:
                I. Executive Summary
                A. Does this action apply to me?
                 This action provides information that is directed to the public in
                general.
                B. What action is the Agency taking?
                 This document lists the statements of findings made by EPA after
                review of submissions under TSCA section 5(a) that certain new chemical
                substances or significant new uses are not likely to present an
                unreasonable risk of injury to health or the environment. This document
                presents statements of findings made by EPA during the reporting
                period.
                C. What is the Agency's authority for taking this action?
                 TSCA section 5(a)(3) requires EPA to review a submission under TSCA
                section 5(a) and make one of several specific findings pertaining to
                whether the substance may present unreasonable risk of injury to health
                or the environment. Among those potential findings is that the chemical
                substance or significant new use is not likely to present an
                unreasonable risk of injury to health or the environment per TSCA
                section 5(a)(3)(C).
                 TSCA section 5(g) requires EPA to publish in the Federal Register a
                statement of its findings after its review of a submission under TSCA
                section 5(a) when EPA makes a finding that a new chemical substance or
                significant new use is not likely to present an unreasonable risk of
                injury to health or the environment. Such statements apply to PMNs,
                MCANs, and SNUNs submitted to EPA under TSCA section 5.
                 Anyone who plans to manufacture (which includes import) a new
                chemical substance for a non-exempt commercial purpose and any
                manufacturer or
                [[Page 12837]]
                processor wishing to engage in a use of a chemical substance designated
                by EPA as a significant new use must submit a notice to EPA at least 90
                days before commencing manufacture of the new chemical substance or
                before engaging in the significant new use.
                 The submitter of a notice to EPA for which EPA has made a finding
                of ``not likely to present an unreasonable risk of injury to health or
                the environment'' may commence manufacture of the chemical substance or
                manufacture or processing for the significant new use notwithstanding
                any remaining portion of the applicable review period.
                D. Does this action have any incremental economic impacts or paperwork
                burdens?
                 No.
                II. Statements of Findings Under TSCA Section 5(a)(3)(C)
                 In this unit, EPA provides the following information (to the extent
                that such information is not claimed as Confidential Business
                Information (CBI)) on the PMNs, MCANs, and SNUNs for which, during this
                period, EPA has made findings under TSCA section 5(a)(3)(C) that the
                new chemical substances or significant new uses are not likely to
                present an unreasonable risk of injury to health or the environment:
                 The following list provides the EPA case number assigned to the
                TSCA section 5(a) submission and the chemical identity (generic name if
                the specific name is claimed as CBI).
                 P-23-0017, Hydrolyzed collagen, polymer with aromatic
                isocyanate, N-triethoxysylil-alkanamine, pectic polysaccharide and poly
                alkyl alcohol (Generic Name).
                 P-23-0068, 1,3-Isobenzofurandione, hexahydro-, polymer
                with 1,4-cyclohexanedimethanol, isononanoate (CASRN 2773548-84-6).
                 To access EPA's decision document describing the basis of the ``not
                likely to present an unreasonable risk'' finding made by EPA under TSCA
                section 5(a)(3)(C), look up the specific case number at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca/chemicals-determined-not-likely.
                 Authority: 15 U.S.C. 2601 et seq.
                 Dated: February 13, 2024.
                Shari Z. Barash,
                Acting Director, New Chemicals Division, Office of Pollution Prevention
                and Toxics.
                [FR Doc. 2024-03364 Filed 2-16-24; 8:45 am]
                BILLING CODE 6560-50-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT